The Prognosis Analysis of Liver Cirrhosis with Acute Variceal Bleeding and Validation of Current Prognostic Models: A Large Scale Retrospective Cohort Study
Table 1
Demographic, clinical, and biochemical characteristics in patients with acute gastrointestinal bleeding ().
N
Age () ()
(range 14-89)
Sex (male)
224 (59.1%)
Cause of cirrhosis
Hepatic B virus
205 (54.1%)
Hepatic C virus
30 (7.9%)
Both hepatic B and C virus
2 (0.5%)
Autoimmune liver disease
42 (11.1%)
Alcoholic
9 (2.4%)
Other
91 (24%)
History of GIB
86 (22.7%)
Ascites
229 (60.4%)
Hepatic encephalopathy
9 (2.4%)
Hepatocellular carcinoma
72 (19%)
Baseline laboratory values, (range)
White blood cell (×109/L)
(0.93-64.86)
Platelet (×109/L)
(1-511)
Red blood cell (×109/L)
(1.2-5.4)
Hemoglobin (g/L)
(23-105)
Albumin (g/dL)
(14.5-55)
Total serum bilirubin (μmol/L)
(2.3-662.4)
Serum creatinine (μmol/L)
(11-513)
International normalized ratio
(0.97-1.74)
Alanine aminotransferase (U/L)
(2.4-734)
Aspartate aminotransferase (U/L)
(8-1244)
Alkaline phosphatase (U/L)
(10-1425)
Gamma-glutamyl transpeptidase (U/L)
(4.4-3331)
Prothrombin time (s)
(1.2-80)
α-Fetoprotein (ng/mL)
(0.19-287000)
Absolute neutrophil count (×109/L)
(0.5-58.8)
Absolute lymphocyte count (×109/L)
(-10.4)
Child-Pugh
A
112 (29.6%)
B
205 (54.1%)
C
62 (16.4%)
Child-Pugh score
(5-13)
MELD score
(5.06-11.9)
NLR score
(0.3-101.4)
CAGIB score
(-7.8-1.6)
In-hospital death
25 (6.6%)
MELD: model for end-stage liver disease; NLR: neutrophil to lymphocyte ratio; CAGIB: cirrhosis acute gastrointestinal bleeding.